Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
01/2002
01/26/2002CA2353193A1 Identifying material from a breast duct
01/24/2002WO2002007100A1 Method, system and program of indicating expression phenomenon of biosystem
01/24/2002WO2002006835A1 Method and device for identifying a polymer sequence
01/24/2002WO2002006834A2 Nested sorting and high throughput screening
01/24/2002WO2002006833A2 Improved non-luminescent substrate
01/24/2002WO2002006832A1 Means of examining nephropathy
01/24/2002WO2002006831A2 Method for establishing the effect of a substance on living cells
01/24/2002WO2002006828A2 Hemoglobin sensor
01/24/2002WO2002006827A1 Compounds and methods for fluorescently labeling nucleic acids
01/24/2002WO2002006821A2 Antimicrobial agent
01/24/2002WO2002006806A2 Antioxidant sensor
01/24/2002WO2002006788A2 Electrochemical method for measuring chemical reaction rates
01/24/2002WO2002006537A2 Methods of identifying renal protective factors
01/24/2002WO2002006536A2 Methods and compositions for perioperative genomic profiling
01/24/2002WO2002006535A2 Method for breeding disease resistant domesticated fowl
01/24/2002WO2002006534A2 Method of diagnosing pulmonary hypertension
01/24/2002WO2002006533A2 Single primer pcr amplification of rna
01/24/2002WO2002006532A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins
01/24/2002WO2002006531A2 Nucleic acid hairpin probes and uses thereof
01/24/2002WO2002006530A2 Methods and materials for assessing cancer aggressiveness
01/24/2002WO2002006529A2 Detection and treatment of polycystic kidney disease
01/24/2002WO2002006528A1 Method and apparatus for the automated generation of nucleic acid ligands
01/24/2002WO2002006527A2 Method for detection of truncated proteins
01/24/2002WO2002006526A1 Detection of copy number changes in colon cancer
01/24/2002WO2002006525A2 Obesity associated biallelic marker maps
01/24/2002WO2002006524A2 A method for direct genetic analysis of target cells by using flourescence probes
01/24/2002WO2002006523A2 Method for detecting pre-disposition to hepatotoxicity
01/24/2002WO2002006522A2 Estrogen receptor gene polymorphisms as markers for determining a predisposition for low bone density
01/24/2002WO2002006521A1 Identification of two principal mutations in ion channels associated with idiopathic generalised epilepsies
01/24/2002WO2002006520A1 Method of screening compound controlling mek/erk signal transduction and medicinal use of the compound
01/24/2002WO2002006519A1 Method of selectively determining glycated hemoglobin
01/24/2002WO2002006518A1 System and method for optimizing tissue barrier transfer of compounds
01/24/2002WO2002006517A2 High-throughput methods for generating and screening compounds that affect cell viability
01/24/2002WO2002006516A1 Methods of modulating angiogenesis
01/24/2002WO2002006514A1 Enzyme activated chemotherapy of liver cancer
01/24/2002WO2002006513A2 A method for treating herpes viruses
01/24/2002WO2002006511A2 Methods for detecting and assaying nucleic acid sequences
01/24/2002WO2002006510A2 Photoselection of nucleic acid ligands
01/24/2002WO2002006509A2 Glucose-1-phosphate thymidylyltransferase and method for selecting inhibitors thereof
01/24/2002WO2002006500A2 Methods of transforming plants and identifying parental origin of a chromosome in those plants
01/24/2002WO2002006484A1 Method of detecting cancer
01/24/2002WO2002006482A1 Receptor protein specifically recognizing bacterial dna
01/24/2002WO2002006478A2 Extracellular matrix protein
01/24/2002WO2002006462A2 Methylated nucleotide regulation of upa gene expression
01/24/2002WO2002006460A2 Masp-2, a complement-fixing enzyme, and uses for it
01/24/2002WO2002006453A2 Regulation of human desc1-like serine protease
01/24/2002WO2002006450A1 Pre-adipose cell lines
01/24/2002WO2002006449A2 Method of detecting compounds that control fungal diseases via effects on sporulation
01/24/2002WO2002006446A2 Haplotypes of the edg6 gene
01/24/2002WO2002006328A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
01/24/2002WO2002006327A2 A method for prognosing cancer and the proteins involved
01/24/2002WO2002006311A2 Olfactory g-protein coupled receptor
01/24/2002WO2002006306A2 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY
01/24/2002WO2002006303A2 Dna vaccines encoding hiv accessory proteins
01/24/2002WO2002006294A2 Haplotypes of the mmp13 gene
01/24/2002WO2002006242A2 5-substituted 2-aryl-4-pyrimidinones
01/24/2002WO2002005930A1 Device and methods for subdividing and filtering gel material and extracting molecules therefrom
01/24/2002WO2002005860A1 Radioligand and binding assay
01/24/2002WO2002005857A2 Phosphatonin-related gene and methods of use thereof
01/24/2002WO2001085215A9 METHODS OF MODULATING FUNCTIONS OF POLYPEPTIDE GalNAc TRANSFERASES AND OF SCREENING SUBSTANCES THEREFOR, PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH AGENTS
01/24/2002WO2001082780A3 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
01/24/2002WO2001082776A3 Methods and compositions for the diagnosis of schizophrenia
01/24/2002WO2001079526A3 Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes
01/24/2002WO2001079234A3 Haplotypes of the apoe gene
01/24/2002WO2001074130A3 A computer based method for identifying conserved invariant peptide motifs
01/24/2002WO2001064900A3 Aspartate carbamyltransferase as herbicidal target
01/24/2002WO2001064750A3 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis
01/24/2002WO2001059073A3 Cytotoxic t lymphocytes activated by dendritic cell hybrids
01/24/2002WO2001055324A3 Nucleic acids, proteins, and antibodies
01/24/2002WO2001052892A3 Jak/stat pathway inhibitors and the uses thereof
01/24/2002WO2001051515A3 Genes differentially expressed in breast cancer
01/24/2002WO2001046258A3 Transporters and ion channels
01/24/2002WO2001044494A3 P450 enzyme substrate
01/24/2002WO2001044286A3 Five-helix protein
01/24/2002WO2001042505A3 Fluorescent quenching detection reagents and methods
01/24/2002WO2001040801A3 Diagnosis and treatment for helicobacter pylori induced colic
01/24/2002WO2001038498A3 A new genotype of hepatitis b virus
01/24/2002WO2001036977A8 Identification of disease markers involving mass-based-separation
01/24/2002WO2001036470A3 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides
01/24/2002WO2001034840A3 Genetic compositions and methods
01/24/2002WO2001034772A3 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS
01/24/2002WO2001032910A3 27 human secreted proteins
01/24/2002WO2001031342A3 DIAGNOSIS AND TREATMENT OF CANCER USING StAR POLYPEPTIDES AND POLYNUCLEOTIDES
01/24/2002WO2001025488A3 Method for enrichment of natural antisense messenger rna
01/24/2002WO2001025483A3 Compositions for dna amplification, synthesis, and mutagenesis
01/24/2002WO2001025436A3 Endozepine-like polypeptides and polynucleotides encoding same
01/24/2002WO2001023616A3 Method of identifying pathogenic cryptococci
01/24/2002WO2001023409A8 38 human secreted proteins
01/24/2002WO2001019860A3 Proteins associated with cell differentiation
01/24/2002WO2001019855A3 Pharmaceutical compositions and methods of using secreted frizzled related protein
01/24/2002WO2001016290A3 Dna encoding the human serine protease eos
01/24/2002WO2001016181A3 Crystal structures of domains of receptor protein tyrosine kinases and their ligands
01/24/2002WO2001012856A3 Analysis of sequence tags with hairpin primers
01/24/2002WO2001012819A3 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders
01/24/2002WO2000075373A3 Combinatorial decoding of random nucleic acid arrays
01/24/2002WO2000073478A9 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
01/24/2002WO2000073453A9 T-bet compositions and methods of use thereof
01/24/2002WO2000073338A9 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
01/24/2002WO2000060123A3 Method for selecting primers for amplification of nucleic acids
01/24/2002US20020010952 Nucleotide sequences coding plant protein; for use in hop culturing